Pharmaceutical Manufacturing News
Schneider Electric
Schneider Electric launches new data centre solutions
Schneider Electric, a company in the digital transformation of energy management and automation, has announced new data centre solutions specifically engineered to meet the intensive demands of next-generation AI cluster architectures.
13 Jun 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
Adwo Shutterstock
Fujifilm rebrands life sciences companies
FUJIFILM Corporation's Life Sciences Group companies has announced new names and identities as part of a strategic positioning effort.
3 Jun 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
Hananeko_Studio Shutterstock
Kaida BioPharma announces partnership with Northway Biotech
Kaida BioPharma, an earlystage pharma company dedicated to advancing targeted anti-cancer therapies to address hormone-driven cancers affecting women, has entered into a manufacturing agreement with Northway Biotech, for the manufacturing of KAD101.
22 May 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
Natoli Engineering
Natoli Engineering introduces EZ Level Feeder Base Leveling System
Natoli Engineering is unveiling the EZ Level Feeder Base Leveling System, Part Number SU 2970.
22 May 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
GC Biopharma
GC Biopharma partners with Körber
GC Biopharma, a South Korean biopharmaceutical company, has partnered with global tech leader Körber to implement a large-scale Manufacturing Execution System (MES) project across multiple sites.
20 May 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
ACG unveils patented personalised capsule technology
ACG, a provider of fully integrated manufacturing solutions, introduces its "world-first" Personalised Capsule Machine (PCM) – a patented technology that creates custom-formulated supplement capsules tailored to individual needs on demand.
19 May 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
Single Use Support
How does process intensification advance bioprocessing?
Khalil Essani, product line manager sterile products at Single Use Support explains how process intensification advances bioprocessing.
12 Jun 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Dave Hoeek Shutterstock
Q&A: Choosing the right CDMO partner
Nigel Stapleton, VP of business development - head of Europe at Mabion, shares insights into choosing the right CDMO partner.
10 Jun 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Faizal Ramli Shutterstock
Q&A: What are the benefits of using a CRDMO?
European Pharmaceutical Manufacturer asks John McDermott, vice president of scientific consulting at Quotient Sciences what the benefits are of using a CRDMO?
5 Jun 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Sponsored Content
Tjoapack
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Experience. Precision for Advanced Therapy Logistics.
Delivering Temp-Critical Therapy to Korea with Real-Time Monitoring, Cold Chain Control and Life-Saving Precision.
Alex Tao Wang Shutterstock
Shilpa Medicare signs commercial supply deal with Orion
Shilpa Biocare, a fully-owned subsidiary of Shilpa Medicare, announces ahead of BIO Boston that it has secured a Europe-wide commercial supply agreement with Orion Corporation for Recombinant Human Albumin.
16 Jun 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Cytiva
Cytiva completing $1.6 billion in investments
Cytiva, a Danaher company, has completed expansion projects in several locations in the United States, Europe, and Asia.
16 Jun 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Photon photo Shutterstock
Rare disease biotech announces milestone
Oxford-based SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease (H-ABC), says it has identified the drug it will take forward into clinical trials.
13 Jun 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Schneider Electric
Schneider Electric launches new data centre solutions
Schneider Electric, a company in the digital transformation of energy management and automation, has announced new data centre solutions specifically engineered to meet the intensive demands of next-generation AI cluster architectures.
13 Jun 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
CKA Shutterstock
RBQM event returns for 2025
CluePoints, the sponsor of RBQMLive and provider of statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual RBQMLive.
13 Jun 2025
Body Stock Shutterstock
XL-protein grants worldwide license to Grifols
XL-protein has announced that it has entered into a worldwide License, Development and Commercialisation Agreement with Grifols for a long-acting biopharmaceutical product.
12 Jun 2025
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
Tjoapack
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Experience. Precision for Advanced Therapy Logistics.
Delivering Temp-Critical Therapy to Korea with Real-Time Monitoring, Cold Chain Control and Life-Saving Precision.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00